Today: 30 June 2026
Browse Category

NASDAQ:KRRO 13 November 2025

Korro Bio (KRRO) Stock Crashes as Novo Nordisk Pauses Pact, KRRO‑110 Disappoints and 34% Layoffs Extend Cash Runway – What Investors Need to Know Today

Korro Bio (KRRO) Stock Crashes as Novo Nordisk Pauses Pact, KRRO‑110 Disappoints and 34% Layoffs Extend Cash Runway – What Investors Need to Know Today

Korro Bio, Inc. is at the center of one of biotech’s biggest shake‑ups of 2025. After releasing mixed early data from its lead RNA‑editing program, KRRO‑110, the company has announced deep layoffs, a strategic pivot in its pipeline and a 12‑month pause in its high‑profile collaboration with Novo Nordisk. The stock has responded with a brutal collapse. As of Thursday, 13 November 2025, here’s a full rundown of everything that has hit the tape around Korro Bio today and what it could mean for KRRO shareholders.
13 November 2025
··

Stock Market Today

  • Dycom Industries (DY) gains 12.6% in 12 weeks on momentum signals
    June 30, 2026, 10:23 AM EDT. Dycom Industries (DY) has put up a 12.6% price move over the past 12 weeks and is up 9.1% in the last month, showing steady price momentum for trend-focused investors. Shares are now trading at 96.2% of their 52-week range, which could point to a possible breakout. The stock carries a Zacks Rank #2 (Buy) and sits in the top 20% for earnings estimate revisions and earnings surprises-usually big for short-term swings. It also holds an Average Broker Recommendation of #1 (Strong Buy), often seen as a gauge of positive sentiment. This mix of price strength and solid analyst ratings is keeping DY on the radar of traders looking for momentum setups.
Go toTop